Follow the 에이비온 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에이비온 has logged 81 public disclosures. The latest transaction was reported on 15 June 2026 (Sale). Among the most active insiders: 신영기. The full history is accessible without an account.
78
Insider Decl.
n/a
Thresholds
n/a
27 ops.
Buy Volume
n/a
11 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Listed on the XKRX market, 에이비온 is a company operating in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.